Tardive Dyskinesia: An Expert’s Guide

Learn the latest about personalized treatment of patients with tardive dyskinesia.

Jonathan M. Meyer, MD
John J. Miller, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 2.04 MB
Released: April 22, 2021

Acknowledgements

This activity is provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Produced in collaboration with
This program is supported by educational grants from
AbbVie Inc.
Intra-Cellular Therapies
Neurocrine Biosciences
Sunovion

Related Content

Clinical Care Options (CCO) commentary by Joseph P. McEvoy, MD, on the assessment of tardive dyskinesia via telepsychiatry

Joseph P. McEvoy, MD Released: May 4, 2021

Watch one of the world’s leading experts address the diagnostic challenges, including differential diagnosis in patients with TD.

John M. Kane, MD Physicians: maximum of 1.25 AMA PRA Category 1 Credits Registered Nurses: 1.1 Nursing contact hours Pharmacists: 1.25 contact hours (0.125 CEUs) Physician Assistants: maximum of 1.25 hours of AAPA Category I (Preapproved) credits Released: June 22, 2020 Expired: June 22, 2021

Watch one of the world’s leading experts address the diagnostic challenges, including differential diagnosis in patients with TD.

Joseph P. McEvoy, MD Physicians: maximum of 0.75 AMA PRA Category 1 Credits Registered Nurses: 0.7 Nursing contact hours Pharmacists: 0.75 contact hours (0.075 CEUs) Physician Assistants: maximum of 0.75 hours of AAPA Category I (Preapproved) credits Released: June 22, 2020 Expired: June 22, 2021

Leslie Citrome, MD, MPH Physicians: maximum of 1.25 AMA PRA Category 1 Credits Registered Nurses: 1.2 Nursing contact hours Pharmacists: 1.25 contact hours (0.125 CEUs) Physician Assistants: maximum of 1.25 hours of AAPA Category I (Preapproved) credits Released: March 15, 2020 Expired: No longer available for credit

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue